Entasis Therapeutics Holdings

Entasis Therapeutics is a holding company. Through its subsidiary, the company is clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria.
  • TickerETTX
  • ISINUS2936141033
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

Wedbush Research

Wedbush Morning Call - Apr 01 2020 6:58AM

Wedbush Research

Wedbush Morning Call - Mar 29 2020 5:56PM

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Wedbush Research

Wedbush Morning Call - Apr 01 2020 6:58AM

Wedbush Research

Wedbush Morning Call - Mar 29 2020 5:56PM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ValuEngine Rating and Forecast Report for ETTX

ResearchPool Subscriptions

Get the most out of your insights

Get in touch